• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Congressional requests received in the month

Dictionary: The Office of the Center Director (OCD) is responsible for answering the Congress’s questions about the work done by CTP. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, and document requests. OCD’s goal is to respond to all Congressional and letter correspondence in a timely manner. OCD and the Office of Legislation established a Memorandum of Understanding (MOU) that outlines targets for responding to Congressional requests and inquiries.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A3
Nov 2010N/A2
Dec 2010N/A0
Jan 2011N/A0
Feb 2011N/A3
Mar 2011N/A4
Apr 2011N/A4
May 2011N/A0
Jun 2011N/A0
Jul 2011N/A1
Aug 2011N/A2
Sep 2011N/A2

FY 2011 Total: 25

Total number of Congressional correspondence received in the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A1
Nov 2010N/A1
Dec 2010N/A0
Jan 2011N/A0
Feb 2011N/A3
Mar 2011N/A3
Apr 2011N/A4
May 2011N/A0
Jun 2011N/A0
Jul 2011N/A0
Aug 2011N/A2
Sep 2011N/A2

FY 2011 Total: 16

Total number of Congressional briefing requests received in the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A2
Nov 2010N/A1
Dec 2010N/A0
Jan 2011N/A0
Feb 2011N/A0
Mar 2011N/A1
Apr 2011N/A3
May 2011N/A0
Jun 2011N/A1
Jul 2011N/A1
Aug 2011N/A0
Sep 2011N/A0

FY 2011 Total: 9

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.